Skip to main content

Cardio Diagnostics Holdings, Inc.

CDIOW
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0001870144

No open-market purchases or sales by Cardio Diagnostics Holdings, Inc. insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $139.7K in total; no superinvestor holds it.

Other share classesCDIO

13F holders, Q4 2022

Institutional positions in Cardio Diagnostics Holdings, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
21
+21 vs. Q3 2022
Shares held
1.53M
+1.53M vs. Q3 2022
Total value
$66.9K
+$66.9K vs. Q3 2022
New holders
21
0 more added
Sold out
0
0 more reduced

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CDIOW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 21 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 21 institutionsQ1 2023: 16 institutionsQ2 2023: 13 institutionsQ3 2023: 13 institutionsQ4 2023: 13 institutionsQ1 2024: 12 institutionsQ2 2024: 9 institutionsQ3 2024: 10 institutionsQ4 2024: 6 institutionsQ1 2025: 7 institutionsQ2 2025: 10 institutionsQ3 2025: 10 institutionsQ4 2025: 6 institutionsQ1 2026: 7 institutionsQ2 2026: 7 institutions
Value heldQ4 2022: $66.9K
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $66.9KQ1 2023: $400.2KQ2 2023: $222.7KQ3 2023: $45.4KQ4 2023: $201.7KQ1 2024: $118.6KQ2 2024: $65.5KQ3 2024: $34.6KQ4 2024: $96.7KQ1 2025: $39.6KQ2 2025: $225.9KQ3 2025: $254.3KQ4 2025: $175.1KQ1 2026: $126.1KQ2 2026: $139.7K
Institutions holding CDIOW and their total value by quarter
QuarterHoldersValue
Q2 20267$139.7K
Q1 20267$126.1K
Q4 20256$175.1K
Q3 202510$254.3K
Q2 202510$225.9K
Q1 20257$39.6K
Q4 20246$96.7K
Q3 202410$34.6K
Q2 20249$65.5K
Q1 202412$118.6K
Q4 202313$201.7K
Q3 202313$45.4K
Q2 202313$222.7K
Q1 202316$400.2K
Q4 202221$66.9K
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding Cardio Diagnostics Holdings, Inc.; share changes are against Q3 2022.

Institutions holding CDIOW in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
EHP Funds Inc.364,492$18.0K0.00%+364,492New
Saba Capital Management, L.P.235,597$11.7K0.00%+235,597New
Atw Spac Management LLC100,000$4.95K0.00%+100,000New
K2 Principal Fund, L.P.92,500$4.58K0.00%+92,500New
Polar Asset Management Partners Inc.89,943$4.33K0.00%+89,943New
D. E. Shaw & Co., Inc.74,822$3.70K0.00%+74,822New
Yakira Capital Management, Inc.69,499$3.44K0.00%+69,499New
Rivernorth Capital Management, LLC49,999$2.50K0.00%+49,999New
CNH Partners LLC46,442$2.30K0.00%+46,442New
Walleye Capital LLC42,915$2.12K0.00%+42,915New
Shaolin Capital Management LLC47,000$2.00K0.00%+47,000New
Wolverine Asset Management LLC29,959$1.48K0.00%+29,959New
Gabelli Funds LLC26,290$1.30K0.00%+26,290New
Walleye Trading LLC24,139$1.20K0.00%+24,139New
Gabelli & Co Investment Advisers, Inc.22,410$1.11K0.00%+22,410New
HRT Financial LP36,200$1.00K0.00%+36,200New
Susquehanna International Group, LLP12,483$6180.00%+12,483New
Castle Creek Arbitrage, LLC11,710$5640.00%+11,710New
UBS Group AG52$30.00%+52New
Radcliffe Capital Management, L.P.50,000––+50,000New
Boothbay Fund Management, LLC100,000––+100,000New